Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Bioorganic and Medicinal Chemistry Letters
Journal
Overview
Identity
Overview
Publication Venue For
Development of BRD4 inhibitors as anti-inflammatory agents and antidotes for arsenicals
. 64.
2022
A small diversity library of α-methyl amide analogs of sulindac for probing anticancer structure-activity relationships
. 28:2136-2142.
2018
Diverse amide analogs of sulindac for cancer treatment and prevention
. 27:4614-4621.
2017
Examining the structure-activity relationship of benzopyran-based inhibitors of the hypoxia inducible factor-1 pathway
. 27:1731-1736.
2017
Repurposing of Proton Pump Inhibitors as first identified small molecule inhibitors of endo-β-N-acetylglucosaminidase (ENGase) for the treatment of NGLY1 deficiency, a rare genetic disease
. 27:2962-2966.
2017
Identification of initial leads directed at the calmodulin-binding region on the Src-SH2 domain that exhibit anti-proliferation activity against pancreatic cancer
. 26:1237-1244.
2016
Hydroxychalcone inhibitors of Streptococcus mutans glucosyl transferases and biofilms as potential anticaries agents
. 26:3508-3513.
2016
Synthesis and biological evaluation of ranitidine analogs as multiple-target-directed cognitive enhancers for the treatment of Alzheimer's disease
. 26:5573-5579.
2016
Evaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer's disease.
. 24:1472-1478.
2014
Synthesis and SAR of geminal substitutions at the C5′ carbosugar position of pyrimidine-derived HCV inhibitors
. 22:6967-6973.
2012
Synthesis and SAR of pyridothiazole substituted pyrimidine derived HCV replication inhibitors
. 22:5652-5657.
2012
Pyridofuran substituted pyrimidine derivatives as HCV replication (replicase) inhibitors
. 22:5144-5149.
2012
5-Benzothiazole substituted pyrimidine derivatives as HCV replication (replicase) inhibitors
. 22:3229-3234.
2012
Novel substituted pyrimidines as HCV replication (replicase) inhibitors
. 22:1160-1164.
2012
Discovery of a new molecular probe ML228: An activator of the hypoxia inducible factor (HIF) pathway
. 22:76-81.
2012
Sulfonamides as a new scaffold for hypoxia inducible factor pathway inhibitors
. 21:5528-5532.
2011
Virtual screening to identify lead inhibitors for bacterial NAD synthetase (NADs)
. 19:2001-2005.
2009
Identification of novel inhibitors of bacterial surface enzyme Staphylococcus aureus Sortase A
. 18:380-385.
2008
Synthesis of symmetrical C- and pseudo-symmetrical O-linked disaccharide analogs for arabinosyltransferase inhibitory activity in Mycobacterium tuberculosis
. 17:4527-4530.
2007
Analogs of the marine alkaloid makaluvamines: Synthesis, topoisomerase II inhibition, and anticancer activity
. 17:2890-2893.
2007
Symmetrical and unsymmetrical analogues of isoxyl; active agents against Mycobacterium tuberculosis
. 16:4743-4747.
2006
A new 2-carbamoyl pteridine that inhibits mycobacterial FtsZ
. 14:3161-3164.
2004
Activation and desensitization of heteromeric neuronal nicotinic receptors: Implications for non-synaptic transmission
. 14:1897-1900.
2004
Heterocyclic aminopyrrolidine derivatives as melatoninergic agents.
. 13:4381-4384.
2003
Synthesis and estrogen receptor binding affinities of 7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-ones containing a basic side chain
. 13:1475-1478.
2003
Structure-activity relationships for a series of thiobenzamide influenza fusion inhibitors derived from 1,3,3-trimethyl-5-hydroxy-cyclohexylmethylamine
. 12:3379-3382.
2002
Synthesis of an arabinofuranosyl disaccharide photoaffinity probe for arabinosyltransferase activity in Mycobacterium tuberculosis
. 12:2749-2752.
2002
An approach to the identification of potent inhibitors of influenza virus fusion using parallel synthesis methodology
. 11:2393-2396.
2001
Stereoselective binding of an enantiomeric pair of stromelysin-1 inhibitors caused by conformational entropy factors
. 10:2427-2430.
2000
Salicylamide inhibitors of influenza virus fusion
. 10:1649-1652.
2000
Preparation and use of a photoactivatable glucose-6-phosphate analogue
. 10:535-539.
2000
Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping (vol 9, pg 1901, 1999)
. 9:3259-3259.
1999
Erratum: Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping (Bioorg. Med. Chem. Lett. (1999) 9 (1901) PII: S0960894X99003182)
. 9:3259.
1999
Novel quinolizidine salicylamide influenza fusion inhibitors
. 9:2177-2180.
1999
Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping
. 9:1901-1906.
1999
Uridine phosphorylase inhibitors: Chemical modification of benzyloxybenzyl-barbituric acid and its effects on UrdPase inhibition
. 9:1477-1480.
1999
Homologated aza analogs of arabinose as antimycobacterial agents
. 8:237-242.
1998
Conformationally constrained precursors to retinoic acid analogs which stabilize the 9Z-configuration
. 5:953-958.
1995
Identity
International Standard Serial Number (issn)
0960-894X
Electronic International Standard Serial Number (eissn)
1464-3405